CN102043892B - 用于原料药胃肠道吸收预测的bspk模型的建模和使用方法 - Google Patents
用于原料药胃肠道吸收预测的bspk模型的建模和使用方法 Download PDFInfo
- Publication number
- CN102043892B CN102043892B CN200910197604.9A CN200910197604A CN102043892B CN 102043892 B CN102043892 B CN 102043892B CN 200910197604 A CN200910197604 A CN 200910197604A CN 102043892 B CN102043892 B CN 102043892B
- Authority
- CN
- China
- Prior art keywords
- medicine
- stomach
- small intestine
- drug
- large intestine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Images
Abstract
Description
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200910197604.9A CN102043892B (zh) | 2009-10-23 | 2009-10-23 | 用于原料药胃肠道吸收预测的bspk模型的建模和使用方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200910197604.9A CN102043892B (zh) | 2009-10-23 | 2009-10-23 | 用于原料药胃肠道吸收预测的bspk模型的建模和使用方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102043892A CN102043892A (zh) | 2011-05-04 |
CN102043892B true CN102043892B (zh) | 2014-04-02 |
Family
ID=43910028
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN200910197604.9A Expired - Fee Related CN102043892B (zh) | 2009-10-23 | 2009-10-23 | 用于原料药胃肠道吸收预测的bspk模型的建模和使用方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102043892B (zh) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105223326B (zh) * | 2015-09-23 | 2017-01-18 | 天津中医药大学 | 一种中药口服速释制剂中活性成分的体外分类方法 |
CN106959366B (zh) * | 2017-03-23 | 2019-04-16 | 浙江省农业科学院 | 一种涉及代谢产物的猪体内磺胺间甲氧嘧啶的残留预测方法 |
CN107153771B (zh) * | 2017-05-17 | 2020-06-30 | 许昌学院 | 一种药物分子的同步控制方法及其应用 |
CN110633487B (zh) * | 2019-07-03 | 2023-03-14 | 北京中医药大学 | 直接压片的片剂处方的设计方法 |
CN114187979A (zh) * | 2022-02-15 | 2022-03-15 | 北京晶泰科技有限公司 | 数据处理、模型训练、分子预测和筛选方法及其装置 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1815189A (zh) * | 2006-01-26 | 2006-08-09 | 南京师范大学 | 药物与环糊精的相互作用及其药学性能的拉曼光谱分析方法 |
WO2007044963A2 (en) * | 2005-10-13 | 2007-04-19 | Novokin Biotech Inc. | Development of prodrugs possessing a nitric oxide donor diazen-1-ium-1,2-diolate moiety using in vitro/in silico predictions |
-
2009
- 2009-10-23 CN CN200910197604.9A patent/CN102043892B/zh not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007044963A2 (en) * | 2005-10-13 | 2007-04-19 | Novokin Biotech Inc. | Development of prodrugs possessing a nitric oxide donor diazen-1-ium-1,2-diolate moiety using in vitro/in silico predictions |
CN1815189A (zh) * | 2006-01-26 | 2006-08-09 | 南京师范大学 | 药物与环糊精的相互作用及其药学性能的拉曼光谱分析方法 |
Also Published As
Publication number | Publication date |
---|---|
CN102043892A (zh) | 2011-05-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102043892B (zh) | 用于原料药胃肠道吸收预测的bspk模型的建模和使用方法 | |
Youan | Chronopharmaceutical drug delivery systems: Hurdles, hype or hope? | |
Kostewicz et al. | PBPK models for the prediction of in vivo performance of oral dosage forms | |
Denninger et al. | A rational design of a biphasic dissolution setup—modelling of biorelevant kinetics for a ritonavir hot-melt extruded amorphous solid dispersion | |
Cascone et al. | The influence of dissolution conditions on the drug ADME phenomena | |
Cho et al. | In vitro–in vivo extrapolation (IVIVE) for predicting human intestinal absorption and first-pass elimination of drugs: principles and applications | |
Lu et al. | Biorelevant test for supersaturable formulation | |
Beechinor et al. | The population pharmacokinetics of high-dose methotrexate in infants with acute lymphoblastic leukemia highlight the need for bedside individualized dose adjustment: a report from the Children’s Oncology Group | |
Coombes et al. | Progestogens are metabolized by the gut microbiota: implications for colonic drug delivery | |
Cascone et al. | Pharmacokinetics of Remifentanil: a three-compartmental modeling approach | |
CN202033355U (zh) | 一种用于药物固体制剂体内外相关性评价的仿生系统装置 | |
Chan et al. | Predicting the longitudinally and radially varying gut microbiota composition using multi-scale microbial metabolic modeling | |
Matsumura et al. | Bottom-up physiologically based oral absorption modeling of free weak base drugs | |
Karthikeyan et al. | Modeling of fluid flow, carbohydrate digestion, and glucose absorption in human small intestine | |
Hens et al. | Application of the Gastrointestinal Simulator (GIS) Coupled with In Silico Modeling to Measure the Impact of Coca-Cola® on the Luminal and Systemic Behavior of Loratadine (BCS Class 2b) | |
Cristofoletti et al. | Exploratory investigation of the limiting steps of oral absorption of fluconazole and ketoconazole in children using an in silico pediatric absorption model | |
Chiang et al. | Exploring a kinetic model approach in biopharmaceutics: estimating the fraction absorbed of orally administered drugs in humans | |
Wu et al. | Profiling biopharmaceutical deciding properties of absorption of lansoprazole enteric-coated tablets using gastrointestinal simulation technology | |
Dahan et al. | Optimized in silico modeling of drug absorption after gastric bypass: The case of metformin | |
Dokoumetzidis et al. | Modelling and simulation in drug absorption processes | |
Takagi et al. | In vitro sensitivity analysis of the gastrointestinal dissolution profile of weakly basic drugs in the stomach-to-intestine fluid changing system: explanation for variable plasma exposure after oral administration | |
Sharma et al. | Novel Cannabinoid receptor 2 (CB2) low lipophilicity agonists produce distinct cAMP and arrestin signalling kinetics without bias | |
Wu et al. | Effects of physicochemical parameters on struvite crystallization based on kinetics | |
Lamberti et al. | Gastrointestinal behavior and ADME phenomena: II. In silico simulation | |
Verma et al. | Modeling the dynamics of human liver failure post liver resection |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CP03 | Change of name, title or address |
Address after: Room 202, Building 4, 576 Li Bing Road, 56 Faraday Road, China (Shanghai) Free Trade Pilot Area, Pudong New Area, Shanghai, 201210 Patentee after: SHANGHAI PHARMAEXPLORER Co.,Ltd. Address before: Room 303, 965 Harley Road, Zhangjiang High-tech Park, Shanghai, 201203 Patentee before: Shanghai PharmaExplorer Co.,Ltd. |
|
CP03 | Change of name, title or address | ||
TR01 | Transfer of patent right |
Effective date of registration: 20210317 Address after: Room A018, room 01, 4th floor, area a, building 1, 2829 Jinke Road, China (Shanghai) pilot Free Trade Zone, Pudong New Area, Shanghai 200131 Patentee after: Shanghai Yunyi Health Technology Development Co.,Ltd. Address before: Room 202, Building 4, 576 Li Bing Road, 56 Faraday Road, China (Shanghai) Free Trade Pilot Area, Pudong New Area, Shanghai, 201210 Patentee before: SHANGHAI PHARMAEXPLORER Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140402 Termination date: 20211023 |
|
CF01 | Termination of patent right due to non-payment of annual fee |